Mitochondrial disease Clinical Trials

26 recruitingLast updated: May 21, 2026

There are 26 actively recruiting mitochondrial disease clinical trials across 14 countries. Studies span Phase 1, Not Applicable, Phase 2, Phase 3. Top locations include Philadelphia, Pennsylvania, United States, New York, New York, United States, Houston, Texas, United States. Updated daily from ClinicalTrials.gov.


Mitochondrial disease Trials at a Glance

26 actively recruiting trials for mitochondrial disease are listed on ClinicalTrialsFinder across 6 cities in 14 countries. The largest study group is Phase 1 with 5 trials, with the heaviest enrollment activity in Philadelphia, New York, and Houston. Lead sponsors running mitochondrial disease studies include Children's Hospital of Philadelphia, Centre Hospitalier Universitaire de Nice, and Minovia Therapeutics Ltd..

Browse mitochondrial disease trials by phase

About Mitochondrial disease Clinical Trials

Looking for clinical trials for Mitochondrial disease? There are currently 5 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Mitochondrial disease trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Mitochondrial disease clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 26 trials

Recruiting

Acute Infection in Mitochondrial Disease: Metabolism, Infection and Immunity

Mitochondrial disease
National Human Genome Research Institute (NHGRI)400 enrolled1 locationNCT04419870
Recruiting

Transgenerational Metabolic-Immune Biomarkers of Neurological and Neurodevelopmental Disorders

Brain TumorEpilepsyAutism Spectrum Disorder+3 more
Southwest Autism Research & Resource Center500 enrolled2 locationsNCT04322734
Recruiting

The Natural History of Mitochondrial Diseases

Genetic DiseaseMitochondrial DiseasesNeurological Diseases or Conditions
Neuroscience Research Australia500 enrolled1 locationNCT06504433
Recruiting
Phase 2

Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease

Primary Mitochondrial Disease
Abliva AB180 enrolled35 locationsNCT05650229
Recruiting
Not Applicable

Exercise Training Effects on Muscle Function in Adults With Mitochondrial Myopathy

Mitochondrial MyopathyMitochondrial Diseases
University of Copenhagen22 enrolled1 locationNCT07450690
Recruiting

Mitochondrial Substrate Utilization in the Diabetic Human Heart

Heart FailureInsulin ResistanceMitochondrial Diseases+2 more
Heinrich-Heine University, Duesseldorf500 enrolled1 locationNCT05958706
Recruiting
Phase 1

Validation of Oxygen Nanosensor in Mitochondrial Myopathy

Mitochondrial DiseasesMItochondrial Myopathies
Children's Hospital of Philadelphia24 enrolled1 locationNCT04086329
Recruiting
Phase 1

Validation of Nanosensor Oxygen Measurement

Mitochondrial diseaseMItochondrial Myopathies
Children's Hospital of Philadelphia96 enrolled1 locationNCT06819683
Recruiting

Neurometabolic Profile of Individuals With Primary Mitochondrial Disease

Primary Mitochondrial Disease
Children's Hospital of Philadelphia30 enrolled1 locationNCT06890520
Recruiting

North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)

Mitochondrial DiseasesMitochondrial DisordersMitochondrial Genetic Disorders+2 more
Columbia University1,000 enrolled17 locationsNCT01694940
Recruiting
Phase 3

KHENERFIN Study: A Trial to Evaluate the Efficacy and Safety of Sonlicromanol in Primary Mitochondrial Diseases

Mitochondrial DiseasesMaternally Inherited Diabetes and Deafness (MIDD)Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-like Episodes (MELAS)+1 more
Khondrion BV220 enrolled10 locationsNCT06451757
Recruiting
Phase 1

Study of N-acetylcysteine in the Treatment of Patients With the m.3243A>G Mutation and Low Brain Glutathione Levels

Mitochondrial disease
Michio Hirano, MD18 enrolled1 locationNCT05241262
Recruiting
Phase 1

Applying pGz in Mitochondrial Disease

Mitochondrial DiseasesMItochondrial Myopathies
Children's Hospital of Philadelphia90 enrolled1 locationNCT05569122
Recruiting

Collection of Blood and Skin Samples From Patients With Primary Mitochondrial Diseases and Healthy Volunteers

Primary Mitochondrial Diseases
Minovia Therapeutics Ltd.100 enrolled1 locationNCT06474104
Recruiting

Natural History Study of Mitochondrial Myopathy

Primary Mitochondrial Disease
Children's Hospital of Philadelphia1,300 enrolled1 locationNCT05250375
Recruiting

Mitochondrial Donation: An 18 Month Outcome Study.

Mitochondrial Diseases
Newcastle-upon-Tyne Hospitals NHS Trust25 enrolled1 locationNCT04113447
Recruiting
Phase 2

Evaluate the Safety and Therapeutic Effects of a Single Intravenous Infusion (IV) of Autologous CD34+ Cells Enriched With Allogenic Placenta-derived Mitochondria in Patients With a Diagnosis of Pearson Syndrome (PS)

Mitochondrial DiseasesPearson Syndrome
Minovia Therapeutics Ltd.6 enrolled1 locationNCT06017869
Recruiting

Global Registry and Natural History Study for Mitochondrial Disorders

MDSNARP SyndromeLeigh Syndrome+15 more
LMU Klinikum6,000 enrolled18 locationsNCT05554835
Recruiting
Phase 2

Deoxynucleosides Pyrimidines as Treatment for Mitochondrial Depletion Syndrome

Mitochondrial DiseasesMitochondrial Metabolism DisordersMitochondrial Encephalomyopathy+2 more
Kenneth Myers, MD200 enrolled1 locationNCT04802707
Recruiting
Not Applicable

Enhancement of Quality of Work And Life

Parkinson DiseaseNeuromuscular Diseases (NMD)Mitochondrial Diseases+2 more
Radboud University Medical Center124 enrolled1 locationNCT06573866